Skip to main content
Fig. 1 | Cardio-Oncology

Fig. 1

From: Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational study

Fig. 1

Cumulative incidence of MACE after start of treatment by treatment groups. A: Cumulative incidence of MACE in the entire cohort. (Subdistribution HR (RT only as reference) 1.01 (0.78–1.30), p = 0.969). B: Cumulative incidence of MACE by presence of baseline CVD risk factor. (Subdistribution HR (RT only as reference) None: 1.49 (0.56–3.97); At least one: 0.99 (0.75–1.31) Interaction’s p = 0.431). C: Cumulative incidence of MACE by presence of previous history of MACE. (Subdistribution HR (RT only as reference) No: 1.09 (0.79–1.50); Yes: 0.79 (0.51–1.21) Interaction’s p = 0.238)

Back to article page